Iron deficiency in pulmonary arterial hypertension: perspectives - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles Pulmonary circulation / Pulm Circ Year : 2021

Iron deficiency in pulmonary arterial hypertension: perspectives

Abstract

In left heart failure, iron supplementation (IS) is a first-line treatment option, regardless of anemia. Pulmonary arterial hypertension (PAH), a rare disease leading to right heart failure, is also associated with iron deficiency. While it is a much debated topic, recent evidence demonstrate that restoration of iron stores results in improved right ventricular function and exercise tolerance. Hence, IS may also be considered as an option in the treatment of PAH.
Fichier principal
Vignette du fichier
10.1177_20458940211021301.pdf (154.29 Ko) Télécharger le fichier
Origin : Publication funded by an institution

Dates and versions

inserm-03934812 , version 1 (11-01-2023)

Identifiers

Cite

Marceau Quatredeniers, David Montani, Alain Cohen‐solal, Frédéric Perros. Iron deficiency in pulmonary arterial hypertension: perspectives. Pulmonary circulation / Pulm Circ, 2021, 11 (3), pp.20458940211021301. ⟨10.1177/20458940211021301⟩. ⟨inserm-03934812⟩
7 View
12 Download

Altmetric

Share

Gmail Facebook X LinkedIn More